90 results on '"Hoffmann, Markus"'
Search Results
2. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
3. Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany
4. Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination
5. Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3
6. Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial
7. Carbapenemase-producing Gram-negative bacteria in hospital wastewater, wastewater treatment plants and surface waters in a metropolitan area in Germany, 2020
8. Deicing performance of common deicing agents for winter maintenance with and without corrosion-inhibiting substances
9. The impact of palliative radiotherapy on health-related quality of life in patients with head and neck cancer – results of a multicenter prospective cohort study
10. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis
11. Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
12. Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
13. Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
14. The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
15. A case study on the influence of hydrophilicity on the signal enhancement by dynamic nuclear polarization
16. Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
17. The loss of pancreatic islet NADPH oxidase (NOX)2 improves islet transplantation
18. [YIA] Amplification of ROS/NET formation induces resolution of inflammation
19. Novel H2O2 and NADPH probes to dissect subcellular redox processes in plants
20. SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
21. Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
22. Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
23. SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
24. Dynamic Ca2+ sensitivity stimulates the evolved SARS-CoV-2 spike strain-mediated membrane fusion for enhanced entry
25. Targeting the tissue-complosome for curbing inflammatory disease
26. Stromal cell regulation of inflammatory responses
27. Polyethylene glycol as a green chemical solvent
28. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
29. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
30. Amplification of NET formation induces resolution of inflammation
31. Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease
32. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
33. SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination
34. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
35. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts
36. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
37. SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
38. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
39. Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells
40. HPV DNA/RNA detection in various oral and oropharyngeal biomaterials identifies active HPV infections also in non-neoplastic tonsils
41. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells
42. The interaction of smoking habit, SLPI and AnxA2 in HPV associated head and neck and other cancers
43. No association between HPV-status in tonsillar tissue and sexual behavior of the patients in a northern German population - Critical view of the link between HPV natural history and HPV-driven carcinogenesis
44. Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells
45. Sphingosine prevents binding of SARS–CoV-2 spike to its cellular receptor ACE2
46. Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases
47. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
48. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
49. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
50. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.